Azevedo Ana, Bettencourt Paulo, Almeida Pedro B, Santos Ana C, Abreu-Lima Cassiano, Hense Hans-Werner, Barros Henrique
Department of Hygiene and Epidemiology, University of Porto Medical School, Porto, Portugal.
BMC Cardiovasc Disord. 2007 Jun 7;7:17. doi: 10.1186/1471-2261-7-17.
We aimed to assess whether we could identify a graded association between increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities independently of predicted risk of coronary heart disease by the Framingham risk score.
We conducted a cross-sectional study on a random sample of the urban population of Porto aged 45 years or over. Six hundred and eighty-four participants were included. Data were collected by a structured clinical interview with a physician, ECG and a transthoracic M-mode and 2D echocardiogram. The metabolic syndrome was defined according to ATPIII-NCEP. The association between the number of features of the metabolic syndrome and the cardiac structural and functional abnormalities was assessed by 3 multivariate regression models: adjusting for age and gender, adjusting for the 10-year predicted risk of coronary heart disease by Framingham risk score and adjusting for age, gender and systolic blood pressure.
There was a positive association between the number of features of metabolic syndrome and parameters of cardiac structure and function, with a consistent and statistically significant trend for all cardiac variables considered when adjusting for age and gender. Parameters of left ventricular geometry patterns, left atrial diameter and diastolic dysfunction maintained this trend when taking into account the 10-year predicted risk of coronary heart disease by the Framingham score as an independent variable, while left ventricular systolic dysfunction did not. The prevalence of left ventricular diastolic dysfunction, and the mean left ventricular mass, left ventricular diameter and left atrial diameter increased significantly with the number of features of the metabolic syndrome when additionally adjusting for systolic blood pressure as a continuous variable.
Increasing severity of metabolic syndrome was associated with increasingly compromised structure and function of the heart. This association was independent of Framingham risk score for indirect indices of diastolic dysfunction but not systolic dysfunction, and was not explained by blood pressure level.
我们旨在评估能否识别代谢综合征组成成分数量增加与心脏结构和功能异常之间的分级关联,且该关联独立于弗明汉姆风险评分所预测的冠心病风险。
我们对波尔图市45岁及以上城市人口的随机样本进行了一项横断面研究。共纳入684名参与者。通过医生进行的结构化临床访谈、心电图以及经胸M型和二维超声心动图收集数据。代谢综合征根据ATPIII-NCEP定义。通过3个多变量回归模型评估代谢综合征特征数量与心脏结构和功能异常之间的关联:调整年龄和性别、调整弗明汉姆风险评分所预测的10年冠心病风险、调整年龄、性别和收缩压。
代谢综合征特征数量与心脏结构和功能参数之间存在正相关,在调整年龄和性别后,所有所考虑的心脏变量均呈现一致且具有统计学意义的趋势。当将弗明汉姆评分所预测的10年冠心病风险作为自变量时,左心室几何形态参数、左心房直径和舒张功能障碍仍保持这一趋势,而左心室收缩功能障碍则不然。当将收缩压作为连续变量进一步调整时,左心室舒张功能障碍的患病率以及左心室平均质量、左心室直径和左心房直径随代谢综合征特征数量的增加而显著增加。
代谢综合征严重程度增加与心脏结构和功能受损加剧相关。这种关联对于舒张功能障碍的间接指标而言独立于弗明汉姆风险评分,但对于收缩功能障碍则不然,且不受血压水平的影响。